About Careers MedBlog Contact us

Study Says Breast Cancer Survivors Have High Quality of Life Compared to General Population

by Rajashri on September 23, 2008 at 3:44 PM
Font : A-A+

 Study Says Breast Cancer Survivors Have High Quality of Life Compared to General Population

A new study has found that breast cancer patients who have been treated with lumpectomy and radiation have a high level of overall quality of life even after 15 years of treatment.

The survey, conducted by physicians at Fox Chase Cancer Center, included women with early stage breast cancer treated with breast-conserving surgery and radiation with or without chemotherapy and hormone therapy.


"Treatments for breast cancer may decrease quality of life temporarily, but this is evidence that survivors on average will return to a normal quality of life," said Gary Freedman, M.D., an attending physician in the department of radiation oncology at Fox Chase Cancer Center who led the survey.

The women in the study were asked to complete a brief questionnaire during routine follow-up visits with their oncologist. Out of the 1,050 women surveyed, 32 percent submitted 1 survey, 29 percent submitted 2, 21 percent submitted 3 and 18 percent submitted 4 or more surveys.

The participants were at various points in their follow-up -- from 3 months to 15 years after treatment. The mean follow-up time between treatment and the survey was 3 years.

The researchers used a survey tool, called EQ-5D, a standardized and validated instrument for measuring health outcomes. There are 5 general questions about health including questions about mobility, self-care, anxiety/depression, pain/discomfort, and ability to perform usual activities. The survey allows for three possible levels of response (1 = no problems, 2 = some problems, or 3 = extreme problems). The index scores gathered in this survey were compared to a survey of the general U.S. adult population (Luo et al Med Care 2005; 43:1078-86).

The health states of patients did not show any significant differences depending on the age.The mean index score 5 years after treatment was 0.95 for women ages 18-44, 0.90 for women ages 45-64, and 0.88 for women older than 64. The mean index score 10 years after treatment was 0.96 for women ages 18-44, 0.93 for women ages 45-64, and 0.76 for women older than 64.

After comparison, the mean index scores for the general U.S. female population by age was found to be 0.91 for ages 18-44, 0.84 for ages 45-64, and 0.81 for women over 64.

"These data appear to show breast cancer survivors have a very high quality of life when compared to the general population," said Freedman.

He revealed that in four of the five questions, a statistically significant trend was observed with the women moving between none or some problems over the years following treatment.

As per the question regarding self-care, the patients' trend upped, moving from "no problems" to "some problems." For 3 of the questions-anxiety, pain and ability to do usual activities-- patients reported improved health states from "some problems" to "no problems."

But, there were a very few women (less than 5 percent) who claimed to have extreme problems with pain, usual activity or self care.

The study was presented at the 50th annual meeting of the American Society for Therapeutic Radiology and Oncology.

Source: ANI


Recommended Reading

Latest Cancer News

 Tobacco Use Among Cancer Patients Likely to Increase Symptom Burden
A new study assessed the association of cigarette smoking and vaping on cancer-related symptom burden (fatigue, pain, emotional problems) and quality of life.
Breaking New Ground in Breast Cancer Therapy Without Chemotherapy
Scientists are making strides in personalized breast cancer therapy by developing a highly accurate molecular classifier test for breast cancer patients.
 Prostate Cancer 'Test by Request' Policies: Beneficial or Detrimental
Experts suggest high-income countries implement a comprehensive risk-based approach for prostate-specific antigen (PSA) testing to reduce overdiagnosis and overtreatment.
 Oral Cancer Cells Use Fat as Fuel to Escape from Immunity
New study identifies the role of metabolic comorbidities such as obesity in contributing to the immunogenicity of oral cancer through the immune pathway STING-IFN-I.
 Treating Anal Cancer With Smarter and Kinder Approach
Recent clinical trial results have shown that reducing the dose and duration of radiotherapy treatments for anal cancer may result in fewer side effects.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Study Says Breast Cancer Survivors Have High Quality of Life Compared to General Population Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests